Literature DB >> 4597121

Prazosin: preliminary report and comparative studies with other antihypertensive agents.

G S Stokes, M A Weber.   

Abstract

In a group of 14 hypertensive patients a 10-week course of treatment with prazosin 3-7.5 mg/day produced a significant reduction in mean blood pressure without serious side effects. The fall in diastolic pressure exceeded the response to a placebo by 10 mm Hg or more in 9 patients. The average decrease in diastolic pressure was similar to that produced by methyldopa 750 mg/day or propranolol 120-160 mg/day but the fall in systolic pressure was comparatively smaller, consistent with reported experimental work showing that the drug causes vasodilatation. The hypotensive effect of prazosin 1.5-3 mg/day combined with propranolol was significantly greater than that of propranolol alone and resulted in good control of blood pressure.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4597121      PMCID: PMC1610990          DOI: 10.1136/bmj.2.5914.298

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  3 in total

1.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

2.  Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.

Authors:  R Zacest; E Gilmore; J Koch-Weser
Journal:  N Engl J Med       Date:  1972-03-23       Impact factor: 91.245

3.  Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.

Authors:  T B Gottlieb; F H Katz; C A Chidsey
Journal:  Circulation       Date:  1972-03       Impact factor: 29.690

  3 in total
  7 in total

Review 1.  Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-09       Impact factor: 9.546

2.  Prazosin in normal subjects: plasma levels, blood pressure and heart rate.

Authors:  A J Wood; P Bolli; F O Simpson
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

Review 3.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

Review 4.  Drug treatment of hypertension.

Authors:  P Turner
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

5.  Treatment of hypertension successively with a diuretic, clonidine or a beta-blocking agent and hydralazine.

Authors:  T Pitkäjärvi; P Ala-Laurila; R Ruosteenoja; P Torsti; S E Masar
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

6.  Use of prazosin in management of hypertension in patients with chronic renal failure and in renal transplant recipients.

Authors:  J R Curtis; F J Bateman
Journal:  Br Med J       Date:  1975-11-22

7.  "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.

Authors:  D McAreavey; L E Ramsey; L Latham; A D McLaren; A R Lorimer; J L Reid; J I Robertson; M P Robertson; R J Weir
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.